Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (6284)	5/6/2002 6:12:09 PM
From: russwinter	Respond to of 52153

I'll throw NPSP into the ring with it's advanced portfolio. Conference call and quarter results on Wed., so maybe in this climate it gets tossed out by the nervous, in a margin call or fund redemption? Doesn't look like a name ("small cap" under a billion) the specialists would support, so maybe some more made up prices? Below 24 would be under 500m TV. 30.2 out @ 27= MC 815m- 217m NWC= 598 TV P: 5 III: ALX 1-11 osteoporosis, maintain complete rights III: AMG-7; hyperparathyroidism with AMGN IIb: short bowel syndrome, maintain complete rights